Treatment with AC484 induced highly significant tumour regression and increased survival in all four models (Fig. 3a and Extended Data Fig. 3a ).
← all excerpts
The PTPN2/PTPN1 inhibitor ABBV-CLS-484 unleashes potent anti-tumour immunity.
1
—
—
Treatment with AC484 induced highly significant tumour regression and increased survival in all four models (Fig. 3a and Extended Data Fig. 3a ).